TGap Ventures

HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

NeoChord, Inc. is a medical technology company that specializes in developing devices to address degenerative mitral valve disease (DMR), a condition that can lead to serious complications such as atrial fibrillation and congestive heart failure. The company's flagship product is the NeoChord Artificial Chordae Delivery System, a disposable device designed to repair damaged heart chordae through a small incision while the heart continues to beat. This innovative approach allows for mitral valve repair to be performed via a 2 to 3-inch incision between the ribs, significantly less invasive than traditional methods that require larger incisions and the use of heart-lung machines. Founded in 2007, NeoChord is headquartered in St. Louis Park, Minnesota.

Revenew is a through-channel marketing automation platform that provides businesses with a comprehensive solution for localized marketing. It enables enterprise brands to effectively market through their partners, fostering growth and competition at the local level. The cloud-based platform facilitates collaboration among manufacturers, resellers, and industry groups, allowing for streamlined brand promotion through a distributed marketing approach. Revenew combines content management, campaign orchestration, funding allocation, and lead management, equipping clients with advanced analytics and dashboards to monitor and enhance channel marketing performance. This holistic view of marketing efforts offers control and transparency, making it a valuable tool for businesses of all sizes.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.

Revenew is a through-channel marketing automation platform that provides businesses with a comprehensive solution for localized marketing. It enables enterprise brands to effectively market through their partners, fostering growth and competition at the local level. The cloud-based platform facilitates collaboration among manufacturers, resellers, and industry groups, allowing for streamlined brand promotion through a distributed marketing approach. Revenew combines content management, campaign orchestration, funding allocation, and lead management, equipping clients with advanced analytics and dashboards to monitor and enhance channel marketing performance. This holistic view of marketing efforts offers control and transparency, making it a valuable tool for businesses of all sizes.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.

NeoChord, Inc. is a medical technology company that specializes in developing devices to address degenerative mitral valve disease (DMR), a condition that can lead to serious complications such as atrial fibrillation and congestive heart failure. The company's flagship product is the NeoChord Artificial Chordae Delivery System, a disposable device designed to repair damaged heart chordae through a small incision while the heart continues to beat. This innovative approach allows for mitral valve repair to be performed via a 2 to 3-inch incision between the ribs, significantly less invasive than traditional methods that require larger incisions and the use of heart-lung machines. Founded in 2007, NeoChord is headquartered in St. Louis Park, Minnesota.

Regenesis Biomedical Inc. is a medical device company based in Scottsdale, Arizona, founded in 1996. The company specializes in the research, design, manufacture, and sale of noninvasive regenerative medicine products aimed at alleviating pain and restoring health. Its primary product, the Provant Therapy System, utilizes an electromagnetic field to reduce pain and swelling in skin and soft tissues following surgical procedures. The company serves a diverse clientele that includes healthcare facilities, acute and long-term care hospitals, skilled nursing facilities, rehabilitation centers, outpatient clinics, and home healthcare providers, all catering to patients under physician orders. Through its innovative approach, Regenesis Biomedical strives to enhance the quality of life for patients experiencing post-operative discomfort.

HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

ValenTx, Inc. is a medical device company based in Maple Grove, Minnesota, established in 2002. It specializes in developing minimally invasive therapy solutions aimed at treating obesity and its related metabolic disorders, including type-2 diabetes and hypertension. One of its key innovations is an endoluminal bypass therapy that replicates the anatomical changes associated with the Roux-en-Y gastric bypass procedure using an adjustable, removable, and replaceable device. ValenTx's focus is on providing effective treatment options for individuals struggling with morbid obesity and related health issues.

Small Bone Innovations (SBi) specializes in the development and manufacturing of medical devices aimed at small bones and joints, with a particular emphasis on trauma and arthroplasty. The company provides a range of implants designed for various anatomical areas, including the thumb, hand, wrist, elbow, foot, and ankle. Its product offerings include implants specifically designed to treat basal joint arthritis and those intended for replacing anatomic joint surfaces. SBi's innovations focus on preserving bone structure and minimizing disruption to collateral ligament origins and insertions, as well as soft skeletal implants, thereby enhancing surgical outcomes for patients with joint-related conditions.

InStadium, Inc. operates a live advertising network that connects brands with audiences at sports events throughout the United States. The company utilizes a multiscreen video network to deliver engaging brand messaging through sight, sound, and motion, ensuring that fans remain interested during live events. InStadium serves a wide array of clients, including Fortune 500 companies, by providing innovative marketing solutions across more than 425 professional and collegiate venues. The platform allows for year-round access to various markets, facilitating integrated media and promotional campaigns tailored to specific schedules. Founded in 2003 and based in Chicago, Illinois, InStadium was previously known as Adcommunity Company, Inc. and became a subsidiary of Gimbal, Inc. in 2020.

Provider of retail-based healthcare services. The company offers treatments for allergies, bladder infections, bronchitis, ear infections, pink eye and styes, sinus infections, strep throat and swimmer's ear, enabling users to get healthcare services easily at low cost.